8 Results for "

PrPSc

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "PrPSc" in MCE Product Catalog:

Cat. No.: HY-101855
CAS No.: 882697-00-9
Purity:  99.93%
Synonyms: Anle138b
Target:  

Amyloid-β

Research Areas:  

Neurological Disease

Emrusolmin (Anle138b), an oligomeric aggregation inhibitor, blocks the formation of pathological aggregates of prion protein (PrPSc) and of α-synuclein (α-syn). Emrusolmin strongly inhibits oligomer accumulation, neuronal degeneration, and disease progression in vivo. Emrusolmin has low toxicity and an excellent oral bioavailability and blood-brain-barrier penetration. Emrusolmin blocks Aβ channels and rescues disease phenotypes in a mouse model for amyloid pathology .
loading...
    loading...
Cat. No.: HY-100857
CAS No.: 1315475-30-9
Target:  

Fluorescent Dye

Research Areas:  

Neurological Disease

PrPSc-IN-1 is a fluorescent probe, binds to the misfolded protein PrP Sc, inhibits its accumulation, with an IC50 of 1.6 μM. Anti-prion activity .
loading...
    loading...
Cat. No.: HY-P990167

Research Areas:  

Neurological Disease

Anti-Mouse/Human PrP/prion protein Antibody (TW1) is a mouse-derived IgG2a type antibody inhibitor, targeting to mouse/human PrP/prion protein. Anti-Mouse/Human PrP/prion protein Antibody (TW1) binds to both PrPc (cellular prion protein) and PrPSc (Scrapie Prion Protein) and blocks the interaction of prion protein with tau protein. Anti-Mouse/Human PrP/prion protein Antibody (TW1) can be used for the researches of Alzheimer’s disease (AD) .
loading...
    loading...
Cat. No.: HY-115360
CAS No.: 10024-04-1
Target:  

Prion Protein

Research Areas:  

Others

IND45193 is a compound used to inhibit prion disease, with activity in reducing PrP(Sc) levels. In cells infected with prions, IND45193 can reduce PrP(Sc) levels, and its activity was determined through screening of multiple cell types and concentration-effect relationship studies.
loading...
    loading...
Cat. No.: HY-138865
CAS No.: 119662-55-4
Purity:  98.35%
Target:  

Prion Protein

Research Areas:  

Infection

BiCAPPA is the first bivalent antiprion ligand. BiCAPPA can decrease infectious conformational form of prion protein (PrP Sc) from scrapie-infected cells, with an EC50 of 0.32 μM .
loading...
    loading...
Cat. No.: HY-18956A
CAS No.: 32597-86-7
Synonyms: (E/Z)-Sephin1 hydrochloride; (E/Z)-IFB-088 hydrochloride
Target:  

Phosphatase

Research Areas:  

Neurological Disease

(E/Z)-Icerguastat hydrochloride ((E/Z)-Sephin1 hydrochloride) is a selective inhibitor with activity that prolongs the phosphorylation effects of eIF2α. (E/Z)-Icerguastat hydrochloride protects cells from defects in proteostasis. (E/Z)-Icerguastat hydrochloride was shown to significantly extend the survival of infected prion mice in a mouse model. (E/Z)-Icerguastat hydrochloride effectively reduces PrPSc expression and prion sequence activity in various neuronal cell lines persistently infected with different prion strains .
loading...
    loading...
Cat. No.: HY-RS18367
Research Areas:  

Others

Prnp Mouse Pre-designed siRNA Set A contains three designed siRNAs for Prnp gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-101855R
CAS No.: 882697-00-9
Synonyms: Anle138b (Standard)
Research Areas:  

Neurological Disease

Emrusolmin (Standard) (Anle138b (Standard)) is the analytical standard of Emrusolmin (HY-101855). This product is intended for research and analytical applications. Emrusolmin (Anle138b), an oligomeric aggregation inhibitor, blocks the formation of pathological aggregates of prion protein (PrPSc) and of α-synuclein (α-syn). Emrusolmin strongly inhibits oligomer accumulation, neuronal degeneration, and disease progression in vivo. Emrusolmin has low toxicity and an excellent oral bioavailability and blood-brain-barrier penetration. Emrusolmin blocks Aβ channels and rescues disease phenotypes in a mouse model for amyloid pathology .
loading...
    loading...